
Dapaneu 10mg Tablet
Marketer
Neucure Lifesciences Private Limited
Salt Composition
Dapagliflozin (10mg)
Overview Dapaneu 10mg Tablet
Glucopan 10mg tablets are indicated for monotherapy or combination therapy in managing type 2 diabetes mellitus. They effectively regulate elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular health. Glucopan 10mg tablets may be administered with or without food, ideally at the same time each day, as determined by your physician. Discontinuation should only occur under medical supervision; abrupt cessation can elevate blood sugar, potentially leading to serious consequences such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, as directed by your doctor. Commonly reported adverse events include vaginal yeast infections, upper respiratory tract infections (nasopharyngitis), and urinary tract infections. Significant fluid loss is possible; adequate hydration is crucial to prevent dehydration. Practicing good hygiene can help minimize the risk of genital fungal infections. Prior to commencing treatment, disclose any pre-existing renal or hepatic dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption while on this medication to reduce the likelihood of side effects. Regular blood glucose monitoring is essential throughout treatment.
Primary Ingredients of Dapaneu 10mg Tablet
No text provided. Please provide the text you wish to be rephrased.
Uses of Dapaneu 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dapaneu 10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 10mg Dapaneu tablet whole; do not break, crush, or chew it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
Common Side effects of Dapaneu 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaneu 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 10mg Dapaneu tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, but consistent timing is recommended.
How Dapaneu 10mg Tablet works:
Glycemia-10 tablets are used to manage high blood sugar. They achieve this by increasing urinary sugar excretion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Dapaneu 10mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dapaneu 10mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Dapaneu 10mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dapaneu 10mg tablets is likely inadvisable for individuals with impaired kidney function and should be avoided. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapaneu 10mg tablets can be administered to patients with hepatic impairment without requiring a change in dosage.
What if you forget to take Dapaneu 10mg Tablet :
Should you forget a Dapaneu 10mg Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Dapaneu 10mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
| Behavior Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
